ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Iksuda, LegoChem Expand ADC Alliance contractpharma
June 23, 2021Grants Iksuda access to LegoChem's next generation ADC platform for up to six targets. -
Iksuda Therapeutics raises $47m to progress ADC pipeline pharmatimes
June 08, 2021Newcastle, UK-headquartered Iksuda Therapeutics has announced the closing of a $47m (￡34m) financing round, with the funds to be used to support the advancement of its lead antibody drug conjugate (ADC) assets. -
Iksuda Therapeutics and Femtogenix Sign License Agreement pharmafocusasia
March 07, 2019Iksuda Therapeutics (Iksuda), the next-generation Antibody Drug Conjugate (ADC) company, today announced it has signed a licensing agreement with Femtogenix Limited (FGX), the next-generation ADC payload company.
Pharma Sources Insight January 2025
